|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
CLC bio Part of $7.8 Million EU STATegra Grant to Develop Integral Analysis Platform for Epigenetics
12/12/2012 9:24:53 AM
AARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio announced the participation in the European FP7 project, STATegra, and receives 1.3 million US Dollars out of the total $7.8M project budget. STATegra aims to develop a user-friendly integral analysis platform for different omics data that is capable of providing a more efficient use of genomics technologies. As a first, this project will generate and integrate data obtained in proteomic, metabolomic and epigenomic experiments. "One of the big challenges today is going past the raw sequence data and getting to grips with the complexity of epigenetic processes - how, when, and why are certain genes switched off or expressed?" states Senior Bioinformatics Scientist at CLC bio, Dr. Michael Lappe, and continues, "By working together with leading experimental researchers and using our in-house competences in world-class software-engineering, we aim to leverage a framework which makes this extremely complex network biology understandable. Ultimately our tools will facilitate the translation of massive amounts of data into useful insights that can be applied in clinical settings."
|
|
|
|
|
|
|
|
|
|
|